A comparison of HLA-B*15:02 screening tests before
prescribing carbamazepine
Jaruthamsophon K, Limprasert P
Department of Pathology, Faculty of Medicine, Prince of Songka Unisersity, Songkhla, Thailand
Introduction: HLA-B*15:02 is the most significant biomarker associated with carbamazepine-induced severe cutaneous drug reaction in Asians. A number of HLA-B*15:02 screening tests have been developed to prevent the drug reaction in clinical practice. However, no comparison of these methods has to date been reported.
